Highlights
- Market Cap
- $183.28M
- Enterprise Value
- $138.06M
- EPS (TTM)
- $0.13
- PE Ratio
- 9.96
- PEG Ratio
- 0.01
- Total Revenue (TTM)
- $279.94M
- Gross Profit (TTM)
- $80.79M
- EBITDA (TTM)
- $31.02M
- Year Range
- $0.85 - $2.24
- ROA (TTM)
- 3.42%
- ROE (TTM)
- 4.92%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in OrganiGram Holdings Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
OrganiGram Holdings Inc. (OGI) has returned -20.24% so far this year and 32.67% over the past 12 months. Over the last ten years, OGI has returned -5.73% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
OrganiGram Holdings Inc.
- 1D
- 7.20%
- 1M
- -6.29%
- YTD
- -20.24%
- 6M
- -33.99%
- 1Y
- 32.67%
- 3Y*
- -19.41%
- 5Y*
- -37.24%
- 10Y*
- -5.73%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Aug 27, 2014, OGI's average daily return is +0.06%, while the average monthly return is +0.88%. At this rate, your investment would double in approximately 6.6 years.
Historically, 42% of months were positive and 58% were negative. The best month was Oct 2015 with a return of +167.8%, while the worst month was Dec 2014 at -42.7%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.
On a daily basis, OGI closed higher 44% of trading days. The best single day was Jan 15, 2020 with a return of +45.4%, while the worst single day was Feb 11, 2021 at -38.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.71% | -4.67% | -6.29% | -20.24% | |||||||||
| 2025 | -6.83% | -23.33% | -12.17% | 14.85% | 16.38% | -0.00% | -0.74% | 29.10% | 17.34% | -20.20% | 1.23% | 2.44% | 4.35% |
| 2024 | 26.72% | 24.70% | 3.86% | -1.40% | -19.34% | -9.94% | 9.09% | 10.12% | -2.16% | -5.52% | -11.70% | 6.62% | 22.90% |
| 2023 | 13.63% | -13.20% | -18.88% | -21.88% | -25.80% | 5.12% | -2.56% | 7.89% | -19.51% | -20.45% | 21.90% | 2.34% | -59.06% |
| 2022 | -14.86% | -0.00% | 11.41% | -15.06% | -18.44% | -20.25% | 16.67% | -0.00% | -18.54% | 17.03% | 0.98% | -22.33% | -54.29% |
| 2021 | 37.59% | 65.57% | 14.52% | -23.49% | 20.90% | -10.90% | -8.39% | 1.91% | -13.86% | -3.91% | -7.69% | -14.22% | 31.58% |
Benchmark Metrics
OrganiGram Holdings Inc. has an annualized alpha of 2.28%, beta of 1.18, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since August 28, 2014.
- This stock participated in 181.49% of S&P 500 Index downside but only 74.90% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 2.28%
- Beta
- 1.18
- R²
- 0.07
- Upside Capture
- 74.90%
- Downside Capture
- 181.49%
Return for Risk
Risk / Return Rank
OGI ranks 58 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for OrganiGram Holdings Inc. (OGI) and compare them to a chosen benchmark (S&P 500 Index).
| OGI | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.54 | 0.90 | -0.36 |
Sortino ratioReturn per unit of downside risk | 1.25 | 1.39 | -0.13 |
Omega ratioGain probability vs. loss probability | 1.14 | 1.21 | -0.07 |
Calmar ratioReturn relative to maximum drawdown | 0.74 | 1.40 | -0.66 |
Martin ratioReturn relative to average drawdown | 1.69 | 6.61 | -4.91 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore OGI risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the OrganiGram Holdings Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the OrganiGram Holdings Inc. was 97.37%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current OrganiGram Holdings Inc. drawdown is 95.99%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.37% | May 21, 2019 | 1480 | Apr 8, 2025 | — | — | — |
| -91.9% | Aug 28, 2014 | 279 | Oct 6, 2015 | 261 | Oct 18, 2016 | 540 |
| -50.48% | Oct 16, 2018 | 50 | Dec 27, 2018 | 40 | Feb 26, 2019 | 90 |
| -48.81% | Nov 15, 2016 | 77 | Mar 8, 2017 | 183 | Nov 27, 2017 | 260 |
| -37.76% | Jan 25, 2018 | 51 | Apr 9, 2018 | 41 | Jun 6, 2018 | 92 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of OrganiGram Holdings Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how OrganiGram Holdings Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for OGI, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, OGI has a P/E ratio of 10.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for OGI compared to other companies in the Drug Manufacturers - Specialty & Generic industry. OGI currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for OGI relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, OGI has a P/S ratio of 0.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for OGI in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, OGI has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |